Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
HCV treatment initiation dropped by 31% from March to April 2020 and remained low throughout the year.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.
Low-barrier care and access to multiple services in one place can improve outcomes for people experiencing homelessness or unstable housing.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.